罗非鱼无乳链球菌LrrG-Sip融合基因原核表达载体的构建及表达

Construction and expression of prokaryotic expression vector for LrrG-Sip fusion gene of Streptococcus agalactiae in tilapia

  • 摘要: LrrG和表面免疫原性蛋白(Sip)是无乳链球菌(Streptococcus agalactiae)的2种表面蛋白,具有良好的免疫原性。为获得罗非鱼无乳链球菌表面蛋白LrrG和Sip蛋白的融合蛋白,该试验采用基因拼接技术中的双酶切法分2步逐个将SipLrrG基因插入pCold Ⅱ载体中,构建原核表达载体pCold Ⅱ-LrrG-Sip。将成功构建的融合基因原核表达载体转化感受态细胞BL21(DE3),进行诱导表达条件的优化。结果显示,15 ℃、IPTG 0.5 mmol·L-1诱导9 h,目的蛋白呈可溶状态的表达量最高。Western Blot检测结果显示LrrG-Sip融合蛋白大小与预测一致(162 kDa),说明成功构建了融合基因,为罗非鱼源无乳链球菌亚单位疫苗的研制奠定了基础。

     

    Abstract: LrrG (leucine-rich repeat protein from GBS) and Sip (surface immunogenic protein), which are two kinds of surface antigen proteins from Streptococcus agalactiae in tilapia, have good immunogenicity. To obtain the LrrG-Sip fusion protein via coalescing surface antigen protein LrrG and Sip of S.agalctiae in tilapia, we cloned Sip and LrrG genes into vector pCold Ⅱ one by one using double enzyme method of gene splicing technology, and constructed a prokaryotic expression vector pCold Ⅱ-LrrG-Sip. The recombinant plasmid was transformed into E.coli BL21(DE3), and the result indicated that 9 h, 15 ℃, 0.5 mmol·L-1 IPTG were the optimum inducing conditions under which fusion protein was most soluble and abundant. Western blotting test showed that the LrrG-Sip fusion protein was about 160 kDa, consistent with the prediction (162 kDa), which suggested the prokaryotic expression vector pCold Ⅱ-LrrG-Sip was constructed successfully and laid the foundation for developing subunit vaccines for S.agalctiae in tilapia.

     

/

返回文章
返回